Immunology News and Research

Latest Immunology News and Research

Researchers describe a new approach to treating Parkinson's disease

Parkinson's disease is the second most common, age-related, neurodegenerative disease: In Germany alone, about 300,000 people are affected and experience sometimes major limitations to their quality of life.

20 Mar 2021

How effective has rapid COVID-19 vaccination been in Israel?

Despite high vaccination rates, analysis shows a definite positive impact, but patience is needed to see the real-world impacts in Israel, a pattern that may hold true in other countries also.

19 Mar 2021

Study reveals biomarkers for the prognosis of gastric adenocarcinoma

Low plasma levels of protein TGFB1 and polymorphisms in gene TGFB1 act as biomarkers for the prognosis of gastric adenocarcinoma, according to a study led by the University Complutense of Madrid.

18 Mar 2021

Virtual reality experiences can be used to train professionals in organ donation and transplants

The Donation and Transplantation Institute and Immersium Studio, a UOC spin-off, have developed virtual reality experiences that can be used to train health professionals in the area of organ and tissue donation and transplantation.

18 Mar 2021

Antidiabetic drug could help reduce chronic inflammation in people living with HIV

Metformin, a drug used to treat type-2 diabetes, could help reduce chronic inflammation in people living with HIV (PLWH) who are being treated with antiretroviral therapy (ART), according to researchers at the University of Montreal Hospital Research Centre.

18 Mar 2021

Novel cancer-fighting gene therapy enters phase I clinical trial

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells.

18 Mar 2021

Microbiota modulation and re-establishment of eubiosis could help curb COVID-19 complications

In the paper published in the journal Frontiers in Immunology, the researchers noted that since both the respiratory tract and the gastrointestinal mucosa are affected in COVID-19, it is possible that adjunctive therapies that modulate the gut-lung axis.

18 Mar 2021

Study characterizes shifting neoantigen burden between primary and metastatic tumors within HNSCC

Oncotarget published "Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma" which reported that prior work has characterized changes in the mutation burden between primary and recurrent tumors; however, little work has characterized the changes in neoantigen evolution.

18 Mar 2021

Engineered mouse Intestine Chip platform can help study host-microbiome interactions

Trillions of commensal microbes live on the mucosal and epidermal surfaces of the body and it is firmly established that this microbiome affects its host's tolerance and sensitivity of the host to a variety of pathogens.

16 Mar 2021

HPSE protein found to be a key regulator of cells’ innate defense mechanisms

Researchers at the University of Illinois Chicago have discovered that heparanase, HPSE, a poorly understood protein, is a key regulator of cells' innate defense mechanisms.

15 Mar 2021

Less-educated, unmarried patients less likely to undergo a transplant for mantle cell lymphoma

Mantle cell lymphoma is a malignant disease in which intensive treatment can prolong life. In a new study, scientists from Uppsala University and other Swedish universities show that people with mantle cell lymphoma who were unmarried, and those who had low educational attainment, were less often treated with a stem-cell transplantation, which may result in poorer survival.

13 Mar 2021

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

13 Mar 2021

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.

12 Mar 2021

VEXAS syndrome in men is more common than previously thought

A rare disease first identified in 2020 is much more common than first thought, say researchers at the University of Leeds investigating its origins.

11 Mar 2021

Study: Lowering the activity of KRAS gene can help fight pancreatic cancer

If clinicians could stop mutations of the KRAS gene in pancreatic cancer – which happens in more than 90 percent of pancreatic cancer cases and drastically reduces response to immunotherapy – the chances of improving treatment for this deadly form of cancer would be increased.

11 Mar 2021

Whole genome sequencing may guide blood cancer treatment

For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes.

11 Mar 2021

Researchers discover new molecular target that could treat idiopathic pulmonary fibrosis

Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF).

10 Mar 2021

NTU scientists design new compound that could help reduce overactive immune response

When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself, which may prove fatal in some cases.

10 Mar 2021

New compound can reduce overactivation without impairing the body's immunity response

10 Mar 2021

Study provides accurate data on allergic reactions related to mRNA COVID-19 vaccines

Almost immediately after the first mRNA-based COVID-19 vaccines were authorized for emergency use and were administered to individuals outside of clinical trials, reports of anaphylaxis--a life-threatening whole-body allergic reaction--raised widespread concerns among experts and the public.

10 Mar 2021

Immunology News and Research

Latest Immunology News and Research

Researchers describe a new approach to treating Parkinson's disease

How effective has rapid COVID-19 vaccination been in Israel?

Study reveals biomarkers for the prognosis of gastric adenocarcinoma

Virtual reality experiences can be used to train professionals in organ donation and transplants

Antidiabetic drug could help reduce chronic inflammation in people living with HIV

Novel cancer-fighting gene therapy enters phase I clinical trial

Microbiota modulation and re-establishment of eubiosis could help curb COVID-19 complications

Study characterizes shifting neoantigen burden between primary and metastatic tumors within HNSCC

Engineered mouse Intestine Chip platform can help study host-microbiome interactions

HPSE protein found to be a key regulator of cells’ innate defense mechanisms

Less-educated, unmarried patients less likely to undergo a transplant for mantle cell lymphoma

New vaccination method aims at comprehensive protection against all known influenza mutations

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

VEXAS syndrome in men is more common than previously thought

Study: Lowering the activity of KRAS gene can help fight pancreatic cancer

Whole genome sequencing may guide blood cancer treatment

Researchers discover new molecular target that could treat idiopathic pulmonary fibrosis

NTU scientists design new compound that could help reduce overactive immune response

New compound can reduce overactivation without impairing the body's immunity response

Study provides accurate data on allergic reactions related to mRNA COVID-19 vaccines

Immunology eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics